A role for oncostatin M in inflammatory bowel disease.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 28475567.
- Also identified by DOI 10.1038/nm.4338 and PMC identifier 5527753.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A new study identifies oncostatin M (OSM) as a potential biomarker and therapeutic target for anti-tumor necrosis factor (TNF)-refractory inflammatory bowel disease (IBD), and pinpoints mucosal stromal cells as key players in OSM-mediated inflammation.
Medical subject headings
- Inflammation
- Inflammatory Bowel Diseases